Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy AdultsTimothy A. Driscoll, Ping Liu, Haydar Frangoul et al.|Antimicrobial Agents and Chemotherapy|2011Cited by 73
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy AdultsTimothy A. Driscoll, Ping Liu, Lolie C. Yu et al.|Antimicrobial Agents and Chemotherapy|2011Cited by 63
HESTER: A Phase II Study Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia Experiencing Loss of B-Cell AplasiaMichael W. Boyer, Jennifer Willert, Sonali Chaudhury et al.|Blood|2020Cited by 8
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastomaTristan Knight, Gregory A. Yanik, Kwang Woo Ahn et al.|Bone Marrow Transplantation|2023Cited by 3
ALL-026: Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II StudyMichael W. Boyer, Jennifer Willert, Sonali Chaudhury et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 1